| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $23.52M | $20.57M | – | – | – |
| R&D | $6.42M | $4.93M | – | – | – |
| SG&A | $8.78M | $8.15M | $1.01M | $138.12K | $10.11K |
| Operating Income | -$23.52M | -$20.57M | -$1.01M | -$138.12K | -$10.11K |
| Interest Expense | $218.03K | – | – | – | – |
| Tax Expense | $1.06M | $576.00K | – | – | – |
| Net Income | -$24.76M | -$21.15M | $2.42M | $380.81K | -$10.11K |
| EPS (basic) | -0.3400 | -0.3100 | 0.2700 | 0.1200 | -0.0100 |
| EPS (diluted) | -0.3400 | -0.3100 | 0.2700 | 0.1200 | – |
| Shares (diluted) | $73.27M | $68.05M | $6.60M | $1.34M | – |